In addition, increasing levels of IgG against unmodified proteins such as high-density lipoprotein (HDL) and serum paraoxonase and arylesterase 1 (PON1) were previously reported in patents with CAD [21]. The gene discussed is PON1; the disease is coronary artery disorder.